Literature DB >> 8690451

Histidine-rich glycoprotein binding to T-cell lines and its effect on T-cell substratum adhesion is strongly potentiated by zinc.

H M Olsen1, C R Parish, J G Altin.   

Abstract

Histidine-rich glycoprotein (HRG), a plasma protein that binds heparin and divalent cations, has been implicated in immune regulation through its ability to modulate complement function, macrophage Fc receptor expression and phagocytosis, and its ability to inhibit the proliferation of human peripheral blood T cells in vitro. In the present work we used fluorescence flow cytometry to study the binding of human HRG to the human T-cell lines Jurkat and MT4, and to the murine antigen-specific T-cell clone D10, and to study the effect of divalent cations zinc and copper on this binding. Our results show that HRG binds strongly to these cell lines at 4 degrees, and that the binding is markedly potentiated by physiological concentrations of zinc (20 microM), and to a lesser extent by copper (10 microM). In contrast to previous studies, HRG binding was largely inhibited by 50 micrograms/ml heparin, both in the absence and in the presence of zinc, suggesting that HRG interacts primarily through glycosaminoglycans on the T-cell surface. Studies using confocal fluorescence microscopy indicated that following incubation of MT4 cells with HRG in the presence of zinc at 4 degrees, the HRG was localized exclusively at the plasma membrane, but was actively internalized after incubation at 37 degrees. Interestingly, HRG interfered with the ability of D10 cells to adhere to tissue culture plastic, as well as to laminin-, collagen- or fibronectin-coated culture dishes. This effect was markedly potentiated by 20 microM zinc, and was partially reversed by heparin. The results suggest that zinc markedly potentiates the binding of HRG to T cells, and that HRG and zinc may play an important role in regulating the adhesion of T cells to other cells and the extracellular matrix.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8690451      PMCID: PMC1456418          DOI: 10.1111/j.1365-2567.1996.tb00005.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  26 in total

1.  [Human serum proteins with high affinity to carboxymethylcellulose. II. Physico-chemical and immunological characterization of a histidine-rich 3,8S- 2 -glycoportein (CM-protein I)].

Authors:  N Heimburger; H Haupt; T Kranz; S Baudner
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1972-07

2.  Histidine-rich glycoprotein: an abundant plasma protein in search of a function.

Authors:  L Leung
Journal:  J Lab Clin Med       Date:  1993-05

3.  Physicochemical, immunochemical and functional comparison of human histidine-rich glycoprotein and autorosette inhibition factor.

Authors:  H R Lijnen; D B Rylatt; D Collen
Journal:  Biochim Biophys Acta       Date:  1983-01-12

4.  Autorosette inhibition factor: isolation and properties of the human plasma protein.

Authors:  D B Rylatt; D Y Sia; J P Mundy; C R Parish
Journal:  Eur J Biochem       Date:  1981-10

5.  Interactions of the histidine-rich glycoprotein of serum with metals.

Authors:  W T Morgan
Journal:  Biochemistry       Date:  1981-03-03       Impact factor: 3.162

6.  Anti-self receptors. V. Properties of a mouse serum factor that blocks autorosetting receptors on lymphocytes.

Authors:  D Y Sia; D B Rylatt; C R Parish
Journal:  Immunology       Date:  1982-02       Impact factor: 7.397

7.  Proteolysis of histidine-rich glycoprotein in plasma and in patients undergoing thrombolytic therapy.

Authors:  A Smith; I Nuiry; W T Morgan
Journal:  Thromb Res       Date:  1985-12-01       Impact factor: 3.944

8.  Histidine-rich glycoprotein modulates the anticoagulant activity of heparin in human plasma.

Authors:  H R Lijnen; B Van Hoef; D Collen
Journal:  Thromb Haemost       Date:  1984-04-30       Impact factor: 5.249

9.  The histidine-rich glycoprotein of serum has a domain rich in histidine, proline, and glycine that binds heme and metals.

Authors:  W T Morgan
Journal:  Biochemistry       Date:  1985-03-12       Impact factor: 3.162

10.  Heparin binding properties of human histidine-rich glycoprotein. Mechanism and role in the neutralization of heparin in plasma.

Authors:  H R Lijnen; M Hoylaerts; D Collen
Journal:  J Biol Chem       Date:  1983-03-25       Impact factor: 5.157

View more
  6 in total

Review 1.  Histidine-rich glycoprotein modulation of immune/autoimmune, vascular, and coagulation systems.

Authors:  Miri Blank; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2008-06       Impact factor: 8.667

2.  Ultrastructural Localization of Histidine-rich Glycoprotein in Skeletal Muscle Fibers: Colocalization With AMP Deaminase.

Authors:  Letizia Mattii; Francesco Bianchi; Alessandra Falleni; Sabina Frascarelli; Matilde Masini; Greta Alì; Grazia Chiellini; Antonietta R M Sabbatini
Journal:  J Histochem Cytochem       Date:  2019-12-27       Impact factor: 2.479

3.  Evidence that muscle cells do not express the histidine-rich glycoprotein associated with AMP deaminase but can internalise the plasma protein.

Authors:  A R M Sabbatini; L Mattii; B Battolla; E Polizzi; D Martini; M Ranieri-Raggi; A J G Moir; A Raggi
Journal:  Eur J Histochem       Date:  2011-02-25       Impact factor: 3.188

Review 4.  Functional Regulation of the Plasma Protein Histidine-Rich Glycoprotein by Zn2+ in Settings of Tissue Injury.

Authors:  Kristin M Priebatsch; Marc Kvansakul; Ivan K H Poon; Mark D Hulett
Journal:  Biomolecules       Date:  2017-03-02

Review 5.  Histidine-rich glycoprotein (HRGP): Pleiotropic and paradoxical effects on macrophage, tumor microenvironment, angiogenesis, and other physiological and pathological processes.

Authors:  Yixiao Pan; Lu Deng; Hai Wang; Kang He; Qiang Xia
Journal:  Genes Dis       Date:  2020-08-08

6.  Native electrospray mass spectrometry approaches to probe the interaction between zinc and an anti-angiogenic peptide from histidine-rich glycoprotein.

Authors:  Esther M Martin; Frances D L Kondrat; Alan J Stewart; James H Scrivens; Peter J Sadler; Claudia A Blindauer
Journal:  Sci Rep       Date:  2018-06-05       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.